Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $16
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $16
SI-BONE Analyst Ratings
Truist Lowers Price Target on SI-BONE to $16 From $18, Keeps Buy Rating
Piper Sandler Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $19
Buy Rating Justified: SI-Bone's Growth Potential and Market Expansion Opportunities
Morgan Stanley Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $19
Analyst Ratings For SI-BONE
A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $18 to $32
Truist Financial Remains a Buy on SI-Bone (SIBN)
Needham Maintains Buy on SI-BONE, Lowers Price Target to $19
SI-BONE Analyst Ratings
Buy Rating Affirmed: SI-Bone's Financial Success and Growth Trajectory Outshine Market Expectations
SI-BONE Analyst Ratings
Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $21
Morgan Stanley Lowers Price Target on SI-Bone to $21 From $25, Keeps Overweight Rating
SI-BONE Analyst Ratings
JMP Securities Reiterates Market Outperform on SI-BONE, Maintains $32 Price Target
Positive Outlook for SI-Bone: Robust Revenue Growth and Strategic Advances Reinforce Buy Rating